Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

During the Trading Day
25.51 +1.23 / +5.07%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
25.52 +0.0051 / +0.02%
 
Volume: 10.7K

Today’s Trading

Previous close24.28
Today’s open24.49
Day’s range23.86 - 25.69
Volume982,211
Average volume (3 months)1,085,332
Market cap$889.6M
Dividend yield--
Data as of 4:01pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+149.38%
Earnings growth (this year)-6.98%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+48.60%
P/E ratio6.4
Price/Sales5.42
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+1.01+4.97%
ADROAduro Biotech Inc+0.30+2.14%
EGRXEagle Pharmaceutical...+4.27+7.99%
PTCTPTC Therapeutics Inc+1.28+5.28%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)$0.86
Annual revenue (last year)$406.8M
Annual profit (last year)$149.9M
Net profit margin36.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
President &
Chief Operating Officer
Michael J. Bogda
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

Partner Offers